Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06145165
Status:
RECRUITING
Last Update Posted:
2023-11-24
First Post:
2023-10-27
Brief Title:
A Analgesic Study of Adductor Canal IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Study Overview
Official Title:
A Analgesic Study of Adductor Canal IPACK Block with Liposomal Bupivacaine in Knee Arthroplasty A RandomizedDouble-controlledParallel-controlledSingle-center Study
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the effectiveness of ACB and iPACK block with liposomal bupivacaine for postoperative analgesia in patients undergoing knee arthroplasty
Detailed Description:
The pain after knee arthroplasty limits the patients activities and postoperative recovery and currently there are mainly three analgesic methods intravenous analgesia epidural analgesia and nerve block analgesia There is a lack of studies on whether liposomal bupivacaine if used for ACB and iPACK block can achieve benefits in knee arthroplasty pain management by prolonging sensory nerve block without affecting muscle strength improving patient prognosis and shortening hospitalization days
In this study in order to better evaluate the effect of liposomal bupivacaine for ACB and iPACK biock on the prognosis of patients undergoing knee arthroplasty not only the NRS and AUC of patients in each group will be observed but also the postoperative QoR-15 Quality of Recovery Rating Scale postoperative nausea vomiting and other complications and the number of hospitalization days will be also included as observation indicators The completion of this study can provide a clinical basis for the selection of analgesic regimens for knee arthroplasty and also provide strong evidence-based medical support for the relevant medical decision making of government departments
In this study in order to better evaluate the effect of liposomal bupivacaine for ACB and iPACK biock on the prognosis of patients undergoing knee arthroplasty not only the NRS and AUC of patients in each group will be observed but also the postoperative QoR-15 Quality of Recovery Rating Scale postoperative nausea vomiting and other complications and the number of hospitalization days will be also included as observation indicators The completion of this study can provide a clinical basis for the selection of analgesic regimens for knee arthroplasty and also provide strong evidence-based medical support for the relevant medical decision making of government departments
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None